Overview This page contains the latest trade data of Antisera and other blood fractions. In 2023, Antisera and other blood fractions were the world's 269th most traded product, with a total trade of $13.2B. Between 2022 and 2023 the exports of Antisera and other blood fractions grew by 32.9%, from $9.95B to $13.2B. Trade in Antisera and other blood fractions represent 0.059% of total world trade.
Antisera and other blood fractions are a part of Vaccines, blood, antisera, toxins and cultures.
Exports In 2023 the top exporters of Antisera and other blood fractions were United States ($3.74B), Ireland ($1.92B), Germany ($1.3B), Switzerland ($750M), and Belgium ($663M).
Imports In 2023 the top importers of Antisera and other blood fractions were Poland ($2.05B), Germany ($825M), Argentina ($816M), France ($777M), and United States ($776M).
Ranking Antisera and other blood fractions ranks 100th in the Product Complexity Index (PCI).